Clinical Trial Update: Evaluation of Wet Age-Related Macular Degeneration (AMD) Genetic Profile Interactions With Ranibizumab Treatment Outcomes [NA]

View source ↗

Summary

This is a ClinicalTrials.gov update about a study evaluating how genetic profiles interact with ranibizumab treatment outcomes in wet age-related macular degene…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: McMaster University | Conditions: Age Related Macular Degeneration | NA | Status: COMPLETED